NN didn't come up with GLP1. It's a natural peptide, and people have been taking it for a very long time. Nordisk did get it approved, yes, and that was costly,

NN didn't come up with GLP1. It's a natural peptide, and people have been taking it for a very long time. Nordisk did get it approved, yes, and that was costly, but let's not massively overstate the innovation. Semaglutide is not GLP1, it's a bit different. But it's not the first GLP1 analog. It's not even the first to be approved : AstraZeneca was the first to get a GLP1 agonist approved, in 2005. In fact, it even is used off label for obesity. Nordisk's big break was convincing the regulators to get it approved for obesity and not just type 2 diabetes.